Although three studies utilised data from whole-exome sequencing (WES) of BRCA1 and BRCA2-negative ovarian carcinoma patients19–21, these analysed only a subset of candidate genes in the available data and included non-HGSOC tumour types in their case cohorts. This evidence concerns the gene BRCA1 and ovarian carcinoma.